Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Reduvo

<< Previous

Bullboard Posts

Next >>

Comment by Golddetectoron May 20, 2022 3:36pm

109 Views

Post# 34699329

RE:Reduvo

Yes it is getting closer. I can wait. The concern with Tbp was always the funds. They do a pp and ppl will sell and cover from pp shares issues to market. Now with this partnership the funds are coming from partner that has interest in the company and eventually will hold more 10%. So I can hold without worry. For the next 12 months or so. We definitely have QIXLEEF and Reduvo by then. Gl to longs

<< Previous

Bullboard Posts

Next >>

Global Tungsten Market and Supply Security